GCM
SNDX icon

Graham Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Graham Capital Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-52,790
Closed -$698K – 1499
2024
Q4 		$698K Sell
52,790
-5,149
-9% -$88.1K 0.01% 602
2024
Q3 		$1.12M Sell
57,939
-17,712
-23% -$366K 0.02% 426
2024
Q2 		$1.55M Sell
75,651
-4,535
-6% -$94.9K 0.03% 302
2024
Q1 		$1.91M Buy
80,186
+65,250
+437% +$1.46M 0.04% 260
2023
Q4 		$323K Buy
+14,936
New +$230K 0.01% 704

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return